Company intelligence / Profile preview

Guangdong Sentient Rui Create Biotechnology

Qingyuan, Guangdong, Chinaruifengbio.com ↗

Ownership: Private
Development stage: Other

Overview

Ruigu Biotech offers state-of-the-art technology and scientific expertise for preclinical/non-clinical innovative drug discovery and development. Their core competencies include measurement and evaluation of drug safety assessment. They provide both in vitro and in vivo pharmacokinetic research services as well as experimental animal services to support IND applications. The team includes internationally trained scientists with experience at major pharmaceutical companies such as Bristol Myers Squibb.

Modalities: Small moleculeBiologicAntibody
Industry: Contract Research Organization

Beyond the preview

Go deeper on Guangdong Sentient Rui Create Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangdong Sentient Rui Create Biotechnology.

Explore the full profile